Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
90
Trial Sponsor
Clinical Trial Start Date
January 2, 2006
0Primary Completion Date
January 29, 2008
0Study Completion Date
January 29, 2008
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
migalastat HCl0
Interventional Trial Phase
Phase 20
Official Name
A Phase 2, Open-Label, Multicenter, 12-Week Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AT1001 in Patients With Fabry Disease0
Last Updated
October 30, 2018
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
Study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
